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Abstract—Dermatophytes are the common fungal agents implicated in superficial skin infections 
worldwide, commonly known as tinea. They include species of Trichophyton, Microsporum and 
Epidermophyton. Infections of this organism have dramatically increased in last one decade by misuse 
of topical corticosteroids cream alone or in combination with topical antibacterial and antifungal agents.  
So this study was conducted with the aim to study about culprits (prescribers) and various offending 
agents. This study was conducted on 1239 consecutive patients of tinea between ages 1-70 years. Tinea 
was diagnosed by detailed history and clinical examination. Detailed inquiry was made for topical 
steroid use by recall method or relevant prescriptions.  It was found that out of 1239, 1000 (80.7%) 
patients were using topical corticosteroid in any form. Most common age group was 21-30 years 
(38.3%). Pharmacist appeared as chief culprit (50.4%) and Clobetasol was major offending agent 
(34.8%). Majority (55.3%) of patients applied these formulations for 4 week or more. Study concluded 
that use of topical corticosteroids in tinea has become menace because of unethical manufacture, sales, 
prescription and end misuse by patient. 
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I. INTRODUCTION 
Dermatophytoses constitute a group of superficial fungal infections of keratinized tissues, namely, the 
epidermis, hair, and nails.
1 
The causative fungi are moulds belonging to three asexual genera 
Microsporum, Trichophyton, and Epidermophyton.
2
 The distribution and frequency of dermatophytosis 
and their etiologic agents vary according to the geographic region studied, the socioeconomic level of 
the population, the time of study, the climatic variations, the presence of domestic animals, and age.
3
  
It is an indisputable fact that there is an increase in the prevalence of dermatophytosis over last one 
decade across the country. One of the most formidable enemies that we have encountered in the recent 
times is the irrational fixed drug combination (FDC) creams containing a steroid, antifungal, and 
antibacterial with three to five molecules in the product.
4,5
 The corticosteroid may be added in the 
initial part of the treatment and improper use of the combination creams may lead to both failure of 
treatment and adverse reaction.
6,7 
Topical corticosteroids used in combination with antifungal agents are very often potent molecules like 
Clobetasol propionate, they are available over the counter and are grossly abused which includes 
buying over the counter and applying it for weeks, months and sometimes years.
8-13
 This leads to 
chronic, treatment resistant dermatophytosis which is causing a havoc in India. The present study was 
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undertaken to assess burden of this misuse to draw attention of medical practitioners.  
II. METHODOLOGY 
This hospital based observational study was conducted in Department of Dermatology, Venereology 
and Leprology, JLN Medical College, Ajmer (Rajasthan) India.  
This study included 1239 consecutive patients of age between 1-70 years, having clinically diagnosed 
tinea and who had given a written consent.  
Each patient was evaluated for tinea in detail, including history regarding duration, qualification, name 
of FDCs, culprit and offending agent in FDCs. Out of 1239 such enrolled cases, 1000 patients were 
found using topical corticosteroid in any form. So these 1000 patients were interviewed and detailed 
inquiry was made for topical steroid use by recall method or relevant prescriptions. Information about 
prescriber (culprit) of these offending agents was also inquired. Results were presented in proportions.  
III. RESULT 
In this study, out of 1269 patients enrolled, 1000 (80.7%) patients of tinea were found using topical 
corticosteroid. Out of these 1000 patients having tinea who applied FDCs, there were 678(67.8%) male 
and 322 (32.2%) were female with male-to-female ratio 2.11:1. Maximum 383 patients (38.3%) seen in 
21-30 years age group and patients of 50-60 years were least. In ≤20 year’s males were more whereas 
in 21-30 years females were more. This sex wise distribution of age of these patients were found with 
significant (p<0.001) variation. (Table 1)  
Table 1 
Age and sex wise distribution study population  
S. 
No. 
Age Group 
(in Years) 
Male Female Total 
No. % No. %  
1 ≤20 186 27.43 21 6.52 207 
2 21-30 205 30.24 178 55.28 383 
3 31-40 142 20.94 51 15.84 193 
4 41-50 52 7.67 30 9.32 82 
5 51-60 29 4.28 17 5.28 46 
6 61-70 64 9.44 25 7.76 89 
 Total 678 100.00 322 100.00 1000 
Chi-square =   86.708 with 5 degrees of freedom;   P < 0.001 
In this study, pharmacist of medical stores were chief culprit responsible for 504 (50.4%) patients and 
general practitioner stood second with 186 (18.6%) patients followed by Ayurveda and homeopathy 
treatment 114 (11.4%), paramedical staff 111(11.1%) etc., television advertisement 13(1.3%), 
insufficient treatment from medical college 50(5%). Paramedical staff and dermatologist were 
significantly more culprit in rural patients than urban patients. This residence of patient wise variation 
in type of culprit person was found with significant (p<0.001). (Table 2) 
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Table 2 
Prescriber (Culprit) for Topical Steroid Misuse in Tinea Patients  
S. No. Prescriber (Culprit) 
Urban Rural 
Total 
No. % No. % 
1 Medical store/ pharmacist 230 53.00 274 48.41 504 
2 Paramedical staff 25 5.76 86 15.19 111 
3 General practitioner 101 23.27 85 15.02 186 
4 Ayurveda/ Homeopathy/ Bangali 49 11.29 65 11.48 114 
5 Incomplete treatment 19 4.38 31 5.48 50 
6 Dermatologist 4 0.92 18 3.18 22 
7 T.V Advertisement 6 1.38 7 1.24 13 
 Total 434 100.00 566 100.00 1000 
Chi-square =   36.056 with 6 degrees of freedom;   P < 0.001 
 
In this study, Clobetasol was principal offending component in these formulations found in 348 
(34.8%) patients followed by Betamethasone in 172 (17.2%) patients, Beclomethasone 62(6.2%), 
multiple formulations 10(1%), Hydrocortisone 5(0.5%), Mometasone 10(10%). Whereas 297(29.7%) 
patients did not know about name and nature of formulation.  33(3.3%) individuals received treatment 
in form of local injections. And 22(2.2%) patients were using these FDCs on dermatologists 
prescription. In ≤20 years males were more whereas in 21-30 years females were more. This sex wise 
distribution of offending agents in these patients were found with significant (p<0.001) variation. In 
males who told the name of offending agent used maximum were using Clobetasol followed by 
Betamethasone, Beclomethasone, injectable treatment, Insufficient treatment, Hydrocortisone and 
multipal formulation whereas in females maximum were using Clobetasol followed by Insufficient 
treatment, Betamethasone, Beclomethasone, Ringguard/Ichguard, Mometasone, injectable treatment 
and multipal formulation.  (Table 3) 
Table 3 
Sex wise Misused Offending Agents in Tinea Patients  
S. No. Offending Agents 
Male Female 
Total 
No. % No. % 
1 Clobetasol 244 35.99 104 32.30 348 
2 Betamethasone 141 20.80 31 9.63 172 
3 Beclomethasone 37 5.46 25 7.76 62 
4 Hydrocortisone 8 1.18 0 0.00 8 
5 Mometasone 0 0.00 12 3.73 12 
6 Insufficient treatment 13 1.92 35 10.87 48 
7 Injectable treatments 27 3.98 6 1.86 33 
8 Multiple formulations 3 0.44 4 1.24 7 
9 Ring guard / Itchguard 0 0.00 13 4.04 13 
10 Not told 205 30.24 92 28.57 297 
 Total 678 100.00 322 100.00 1000 
Chi-square = 116.620 with 9 degrees of freedom;   P < 0.001 
Regarding use of these offending agents according to education status of patient it was found that 
maximum such patient were with education primary to less than graduate followed by less than primary 
and more than graduate level. And 553(55.3%) patients applied these formulations for 4 a duration of 
weeks or more including years of application history in 25 (2.5%) patients. Those who were more than 
graduate apply these offending agent less or apply for less period. This variation of duration of use of 
these offending agent according to education status of patient was found significant (p<0.001). 
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Table 4 
Education wise duration of steroid application in Tinea Patients 
S. No. Education 
≤ 2 Weeks 2-4 Weeks ≥4 Weeks 
Total 
No. % No. % No. % 
1 ≤Primary 66 35.68 60 26.09 95 17.18 221 
2 Primary to  < Graduate 74 40.00 140 60.87 380 68.72 594 
3 ≥Graduate 45 24.32 30 13.04 110 19.89 185 
 Total 185 100.00 230 100.00 553 100.00 1000 
Chi-square =   48.144 with 4 degrees of freedom;   P < 0.001 
IV. DISCUSSION 
Misuse of topical corticosteroids in tinea patients was center point of our study to evaluate gravity of 
problem cause by these agents in form of extent, duration, resistance of disease and frequency of 
misuse. Misuse of these agents is due to regulation lacunae at various levels. Manufacturing and 
marketing misuse (in form of FDCs) is shortcoming of government policies over pharmaceuticals 
which allow these organizations to manufacture unethical combinations. Prescriptions and sales misuse 
like prescription of dermatologists may be incomplete with respect to quantity to be used, frequency, 
site, duration  and prescriptions of non-dermatologists who do not consider the potency, site, duration 
and indication (e.g. super potent corticosteroid applied on groin for prolonged period for Tinea cruris) 
are served regularly at sales counters of chemists. With the same prescriptions, patients tend to 
repeatedly buy the same drug from the chemists without bothering to visit the doctor for further 
advice.
14
 However; many of these patients do not consult dermatologists initially or even later and 
apply steroids which are recommended by their friends, neighbors and relatives. It is only when their 
disease is aggravated by steroid application or complications set in either on the short or on the long run 
that they are forced to visit the dermatologist.  
In this study, patients with topical corticosteroid use were 80.7% which is much higher than previous 
studies.
15
 Here, male outnumbered females. Philpot
16
 also suggested that males may be more vulnerable 
to infection due to the higher exposures in the army, school and sporting activities and due to the types 
of shoes and socks used. Maximum patients lying in 21-30 years age group which is different from 
previous authours.
17,18
 This may be due to access of FDCs containing topical corticosteroids in this 
group, ignorance and unawareness of health, accepting recommendations by their friends, neighbors, 
relatives, easy misdirected  internet access, change of lifestyle and wearing tight clothes. All these 
factors mostly operate in this age group. Further, males of rural background suffered more because of 
unavailability of health care services, specialist consultation, poor hygiene and working in hot and 
humid environment.  
Pharmacist/ salesperson at medical store owns 50.4% problem because of poor regulatory command of 
governing bodies. Secondly, there is a concept peculiar to India, where salespersons at chemist counters 
are considered equal to doctors by many lay persons. This peculiar concept arises from the theory that 
the salesman knows more about drugs than doctors since they are selling the drug.  These salespersons 
also encourage such a concept principally to increase their sales and, to some extent, for ego 
satisfaction.
19
  
Topical corticosteroids of almost every potency class was found to be misused but highly potent agent 
constitutes main load which is concordant with previous studies,
8-13
 suggesting unethical manufacture 
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and preference over other agent to claim high efficacy and fast temporary relief which are otherwise not 
justified.  
Majority of patients used these formulations for more than 4 weeks of duration because of their property 
of quick relief and aggravation of disease symptoms on discontinuation, hence forming vicious cycle. 
V. CONCLUSION 
It can be concluded from this study that majority i.e. 80.7% of tenia patients were using topical 
corticosteroid in any form. Pharmacist appeared as chief culprit and Clobetasol was major offending 
agent. Majority of patients applied these formulations for 4 week or more. Study concluded that use of 
topical corticosteroids in tinea has become menace because of unethical manufacture, sales, 
prescription and end misuse by patient. 
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